![New Hope for Cancertherapy: A New Drug Combination for Chemoimmunotherapy ,[object Object]](https://image.slidesharecdn.com/random-100522021553-phpapp01/85/New-Hope-for-Cancertherapy-1-320.jpg)
![Company Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Recommended
More Related Content
What's hot
What's hot (18)
Viewers also liked
Viewers also liked (20)
Similar to New Hope for Cancertherapy
Similar to New Hope for Cancertherapy (20)
Recently uploaded
Recently uploaded (20)
New Hope for Cancertherapy
- 10. Clinical Data Pancreatic Cancer Group N Six Month Survival Rate (%) p One Year Survival Rate ( ％ ) p +Adjuvant 25 64 ＞ 0.05 28 ＜ 0.05 -Adjuvant 20 45 5
- 11. Clinical Data — NSCLC* *Patients were treated with intratumoral therapy, followed by supportive treatment (radiotherapy and EP Chemotherapy ： CBP 0.3 d 1 ， VP-16 0.1 d 1 ～ 4 ) Group Stage N Median Survival Time (M) Six Month Survival Rate (%) One Year Survival Rate (%) - Adjuvant II 10 6.33 50 30 III 20 5.52 45 20 IV 12 4.9 41.67 33.33 Sum 42 7.59 45.23 26.19 + Adjuvant II 8 11.47 100 50 III 33 11.9 69.7 42.42 IV 11 9.77 81.82 45.45 Sum 52 12.66 76.36 45.45
- 12. Clinical Data — NSCLC** **Patients were treated with intratumoral therapy alone Group N Mean Survival Time (M) Median Survival Time (M) Six Month Survival Rate ( ï¼… ) One Year Survival Rate ( ï¼… ) -Adjuvant â… 2 22.5 4 50 50 â…¡ 2 4.5 4.5 0 0 â…¢ 6 3.33 2 16.67 0 â…£ 4 6.15 4.5 50 25 Sum 14 7.04 3.5 28.57 14.29 +Adjuvant â… 5 25.5 13 60 60 â…¡ 2 14 11 50 50 â…¢ 11 18.8 10 72.72 45.45 â…£ 7 2.86 1 28.57 0 Sum 25 15.29 9 64 36
- 13. Clinical Data Relapsed NSCLC Patients were treated with intratumoral therapy, followed by supportive treatment Group N Mean Survival Time (M) Median Survival Time (M) One Year Survival Rate (% ） -Adjuvant 34 7.40 5.32 5.88 +Adjuvant 60 11.99 9.36 20.34
- 15. Clinical Data Side Effect Evaluation SE Sum N ï¼… â… â…¡ â…¢ â…£ Nausea/Vomit 120 6 6 0 0 10 Hair Loss 120 0 0 0 0 0 Leukopenia 120 2 1 1 0 3.33
- 17. IP Status Australia AU60177024 United States US6811788 China ZL01806830.8
- 18. D IND D P C A B ARA-C-T ADM-T E = Exploratory Clinical Testing E Automatic Injector GEMCITABINE-T PTX-T
- 20. World Is Smaller Here